Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis
- 31 January 1996
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 97 (1), 85-94
- https://doi.org/10.1016/s0091-6749(96)70286-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 1993
- Modulation of Leukocyte Cyclic AMP Phosphodiesterase Activity by Recombinant Interferon-γ: Evidence for a Differential Effect on Atopic MonocytesJournal of Interferon Research, 1993
- Increased Interleukin-4 Production by Atopic Mononuclear Leukocytes Correlates with Increased Cyclic Adenosine Monophosphate – Phosphodiesterase Activity and Is Reversible by Phosphodiesterase InhibitionJournal of Investigative Dermatology, 1993
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993
- A new view of prostaglandin E regulation of the immune responseImmunology Today, 1991
- Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitisClinical and Experimental Immunology, 1990
- Evidence that defective interferon-gamma production in dermatitis patients is due to intrinsic abnormalitiesClinical and Experimental Immunology, 1990
- Monocyte Localization of Elevated cAMP Phosphodiesterase Activity in Atopic DermatitisJournal of Investigative Dermatology, 1986
- T Lymphocytes in Atopic ChildrenInternational Archives of Allergy and Immunology, 1976
- SUPPRESSED CELL-MEDIATED IMMUNITY IN TWO ADULTS WITH ATOPIC DERMATITISBritish Journal of Dermatology, 1972